Investors should buy Lufax as the China-based lending company pivots, according to Sanford C. Bernstein. Analyst Tianjiao Yu initiated coverage of the financial technology stock at outperform. The firm's $2.50 price target for U.S.-listed shares implies 59% upside from where the shares closed Wednesday.
Competition is more crowded in consumer lending, and banks are not competitors, but rather "hand-holding partners" in the small- and medium-sized enterprise space as they rely on Lufax for customer acquisition and data, Yu noted. Yu said Lufax could see "take rates" move to 3% at the end of 2027 from 1.3% at the end of 2023 under its full-guarantee model with incremental guarantee income.
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
PGA-LIV merger ‘one of the saddest days’ in golf history: Brandel ChambleeChamblee, 60, has been an outspoken critic of the Saudi-backed LIV tour.
Lire la suite »